Teranishi JI - Search Results

1

Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate.

Miyoshi Y, Uemura K, Kawahara T, Yoneyama S, Hattori Y, Teranishi JI, Ohta JI, Takebayashi S, Yokomizo Y, Hayashi N, Yao M, Uemura H. Miyoshi Y, et al. Among authors: teranishi ji. Clin Genitourin Cancer. 2017 Aug;15(4):472-478. doi: 10.1016/j.clgc.2016.12.020. Epub 2016 Dec 29. Clin Genitourin Cancer. 2017. PMID: 28110835

2

[High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer].

Hasumi H, Kishida T, Teranishi J, Nakaigawa N, Fujinami K, Ikeda I, Uemura H, Yao M, Takeda M, Noguchi S, Kubota Y. Hasumi H, et al. Hinyokika Kiyo. 2002 Aug;48(8):469-73. Hinyokika Kiyo. 2002. PMID: 12243071 Free article. Japanese.

3

Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.

Uemura H, Hasumi H, Kawahara T, Sugiura S, Miyoshi Y, Nakaigawa N, Teranishi J, Noguchi K, Ishiguro H, Kubota Y. Uemura H, et al. Int J Clin Oncol. 2005 Dec;10(6):405-10. doi: 10.1007/s10147-005-0520-y. Int J Clin Oncol. 2005. PMID: 16369744 Clinical Trial.

4

Renin-angiotensin system is an important factor in hormone refractory prostate cancer.

Uemura H, Hasumi H, Ishiguro H, Teranishi J, Miyoshi Y, Kubota Y. Uemura H, et al. Prostate. 2006 Jun 1;66(8):822-30. doi: 10.1002/pros.20407. Prostate. 2006. PMID: 16482568

5

[Questionnaire on suitableness and acceptableness of cancer notification in aged Japanese prostate cancer patients].

Noguchi K, Uemura H, Teranishi J, Fujinami K, Miyoshi Y, Nakaigawa N, Saito K, Kubota Y. Noguchi K, et al. Nihon Hinyokika Gakkai Zasshi. 2006 Jan;97(1):48-56. doi: 10.5980/jpnjurol1989.97.48. Nihon Hinyokika Gakkai Zasshi. 2006. PMID: 16485554 Free article. Japanese.

6

Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease.

Hattori K, Teranishi J, Stolle C, Yoshida M, Kondo K, Kishida T, Kanno H, Baba M, Kubota Y, Yao M. Hattori K, et al. Cancer Sci. 2006 May;97(5):400-5. doi: 10.1111/j.1349-7006.2006.00193.x. Cancer Sci. 2006. PMID: 16630138 Free PMC article.

7

Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia.

Noguchi K, Suzuki K, Teranishi J, Kondo K, Kishida T, Saito K, Uemura H, Kubota Y. Noguchi K, et al. Hinyokika Kiyo. 2006 Jul;52(7):527-30. Hinyokika Kiyo. 2006. PMID: 16910584 Free article.

8

Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer: two case reports.

Noguchi K, Teranishi J, Uemura H, Fujikawa N, Saito K, Murai T. Noguchi K, et al. Int J Urol. 2006 Sep;13(9):1259-61. doi: 10.1111/j.1442-2042.2006.01515.x. Int J Urol. 2006. PMID: 16984567

9

[Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].

Hattori Y, Takizawa A, Kishida T, Kakizoe M, Fujikawa N, Teranishi J, Kondo K, Saito K, Noguchi K, Nakaigawa N, Kubota Y. Hattori Y, et al. Gan To Kagaku Ryoho. 2007 May;34(5):739-43. Gan To Kagaku Ryoho. 2007. PMID: 17496448 Japanese.

10

Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells.

Teranishi J, Ishiguro H, Hoshino K, Noguchi K, Kubota Y, Uemura H. Teranishi J, et al. Prostate. 2008 Nov 1;68(15):1666-73. doi: 10.1002/pros.20835. Prostate. 2008. PMID: 18677709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters